| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.005 |